Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520262-17-000045
Filing Date
2017-10-26
Accepted
2017-10-26 09:29:33
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20170930x10q.htm 10-Q 2033902
2 EX-31.1 alks-20170930ex311497560.htm EX-31.1 47478
3 EX-31.2 alks-20170930ex31291d0c2.htm EX-31.2 47572
4 EX-32.1 alks-20170930ex321cc1b3d.htm EX-32.1 21144
5 GRAPHIC alks20170930x10q001.jpg GRAPHIC 4994
6 GRAPHIC alks20170930x10q002.jpg GRAPHIC 24297
7 GRAPHIC alks20170930x10q003.jpg GRAPHIC 13438
8 GRAPHIC alks20170930x10q004.jpg GRAPHIC 93247
  Complete submission text file 0001520262-17-000045.txt   7114246

Data Files

Seq Description Document Type Size
9 EX-101.INS alks-20170930.xml EX-101.INS 1534778
10 EX-101.SCH alks-20170930.xsd EX-101.SCH 36636
11 EX-101.CAL alks-20170930_cal.xml EX-101.CAL 67054
12 EX-101.DEF alks-20170930_def.xml EX-101.DEF 118175
13 EX-101.LAB alks-20170930_lab.xml EX-101.LAB 403677
14 EX-101.PRE alks-20170930_pre.xml EX-101.PRE 265209
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 171155045
SIC: 2834 Pharmaceutical Preparations